Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.
Journal: JAMA
Published: July 29, 2026
Finerenone and Blood Pressure in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial.
Journal: JAMA cardiology
Published: July 08, 2026
Obesity and Multiple Long-term Cardiovascular-Kidney-Metabolic Conditions in U.S. Adults.
Journal: Diabetes care
Published: June 03, 2026
Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical Trials.
Journal: JAMA cardiology
Published: June 03, 2026
Time in blood pressure range and cardiovascular outcomes in HFmrEF/HFpEF: a pooled participant-level analysis of four large-scale trials.
Journal: European journal of heart failure
Published: May 29, 2026
A Dyssynchronous Phenotype, A Delayed Therapy: Rethinking the Timing of CRT in Heart Failure.
Journal: Journal of cardiac failure
Published: May 21, 2026
The HFpEF-ABA Score, Incident Heart Failure, and Finerenone in Chronic Kidney Disease with Type 2 Diabetes.
Journal: Journal of cardiac failure
Published: May 21, 2026
Interruption of Early Cardiovascular Risk Pathways With GLP-1-Based Therapy for Obesity.
Journal: Journal of the American College of Cardiology
Published: May 07, 2026
Cardiologists as Champions of Kidney Health in the CKM Era.
Journal: Journal of the American College of Cardiology
Published: May 07, 2026
Treatment with finerenone in people with heart failure and mildly reduced or preserved ejection fraction: a plain language review.
Journal: Future cardiology
Published: April 28, 2026
Is Placebo Still Ethical in Trials of Incretin Therapies?
Journal: Circulation
Published: April 06, 2026
Last Updated: 09/26/2026